Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma: Initial results

NuklearMedizin

Volumn 48, Issue 5, 2009, Pages 185-191

  Aschoff, P ^a   Hantschel M ^a   Oksuz M ^a   Werner, M K ^a   Lichy, M ^a   Vogel, W ^a   Pfannenberg, C ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

FDG; Granulocytic sarcoma; Leukaemia; PET CT

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DASATINIB; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; FLUORODEOXYGLUCOSE F 18; GEMTUZUMAB OZOGAMICIN; HYDROXYUREA; IDARUBICIN; IMATINIB; MELPHALAN; MITOXANTRONE; PREDNISOLONE; THIOTEPA; TOPOTECAN; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRANULOCYTIC SARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY ANALYSIS;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SARCOMA, MYELOID; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 70350319789     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0236     Document Type: Article

References (25)

1. Au WY, Shek TW, Ma SK et al. Myeloblastoma (chloroma) in leukemia: case 2. Meningeal granulocytic sarcoma (chloroma) in essential thrombocythemia. J Clin Oncol 2000; 18: 3996-3997.
2. Békássy AN, Hermans J, Gorin NC et al. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1996; 17: 801-808. (Pubitemid 26156317)
3. Bruzzi JF, Macapinlac H, Tsimberidou AM et al. Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med 2006; 47: 1267-1273. (Pubitemid 47544878)
4. Byrd JC, Edenfield WJ, Shields DJ et al. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 1995; 13: 1800-1816.
5. Eade T, Tan B, Mansberg R et al. An unusual case of chloroma without marrow involvement demonstrated on Ga-67 scintigraphy. Clin Nucl Med 2002; 27: 359-360. (Pubitemid 34437679)
6. Endo T, Sato N, Koizumi K et al. Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia. Am J Hematol 2004; 76: 279-282. (Pubitemid 38828851)
7. Finnegan DP, Jones FG, McMullin MF. Acute myeloid leukemia with concurrent myeloid sarcoma treated with autologous bone marrow transplantation: two illustrative cases and a literature review. Hematol Oncol 2005; 23: 133-135.
8. Guermazi A, Feger C, Rousselot P et al. Granulocytic sarcoma (chloroma): imaging findings in adults and children. Am J Roentgenol 2002; 178: 319-325. (Pubitemid 34098032)
9. Inoue T, Takahashi T, Shimizu H et al. Spinal granulocytic sarcoma manifesting as radiculopathy in a nonleukemic patient. Neurol Med Chir (Tokyo) 2008; 48: 131-136.
10. Karlin L, Itti E, Pautas C et al. PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma. Haematologica 2006; 91: ECR54.
11. Kostakoglu L, Goldsmith SJ. Positron emission tomography in lymphoma: comparison with computed tomography and Gallium-67 single photon emission computed tomography. Clin Lymphoma. 2000; 1: 67-74.
12. Krause BJ, Beyer T, Bockisch A et al. FDG-PET/CT in oncology. German Guideline. Nuklearmedizin 2007; 46: 291-301.
13. 18F]-fluoro-D-glucose. Mol Imaging Biol 2002; 4: 179-183.
14. La Fougere C, Hundt W, Brockel N et al. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 2006; 33: 1417-1425. (Pubitemid 44885407)
15. 67Ga scintigraphy in granulocytic sarcoma. Cancer 1980; 46: 1357-1359.
16. 18F-fluorodeoxyglucose PET. Clin Nucl Med 2008; 33: 115-117.
17. Menasce LP, Banerjee SS, Beckett E et al. Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology 1999; 34: 391-398. (Pubitemid 29244162)
18. Nakajo M, Jinnouchi S, Inoue H et al. FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment. Clin Nucl Med 2007; 32: 775-778. (Pubitemid 47476342)
19. Neiman RS, Barcos M, Berard C et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981; 48: 1426-1437. (Pubitemid 11042596)
20. Takalkar A, Yu JQ, Kumar R et al. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography. Clin Nucl Med 2004; 29: 637-639. (Pubitemid 40228171)
21. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
22. Tsimberidou AM, Kantarjian HM, Estey E et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia 2003; 17: 1100-1103. (Pubitemid 36733479)
23. Weber WA, Figlin R. Monitoring cancer treatment with PET/CT: does it make a difference? J Nucl Med 2007; 48: 36S-44S.
24. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer 2002; 94: 1739-1746. (Pubitemid 34241112)
25. 18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC Recommendations. Eur J Cancer 1999; 35: 1773-1782.